IL162868A0 - Depot medicament, carrier materials for depot medicaments, and method for the production thereof - Google Patents

Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Info

Publication number
IL162868A0
IL162868A0 IL16286803A IL16286803A IL162868A0 IL 162868 A0 IL162868 A0 IL 162868A0 IL 16286803 A IL16286803 A IL 16286803A IL 16286803 A IL16286803 A IL 16286803A IL 162868 A0 IL162868 A0 IL 162868A0
Authority
IL
Israel
Prior art keywords
depot
carrier
carrier materials
medicament
medicaments
Prior art date
Application number
IL16286803A
Original Assignee
Stoess & Co Gelatine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoess & Co Gelatine filed Critical Stoess & Co Gelatine
Publication of IL162868A0 publication Critical patent/IL162868A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)

Abstract

Disclosed are a depot medicament containing a pharmacological agent and a carrier, particularly a depot medicament to be administered parenterally, carrier materials for depot medicaments, and a method for producing said carrier materials. A set amount of an agent is released over time while the agent is preserved in its pharmacologically effective form. The carrier is produced by using a carrier material comprising a carrier polymer formed by a polypeptide and a biodegradable polyester which is covalently linked thereto.
IL16286803A 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof IL162868A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206517A DE10206517A1 (en) 2002-02-16 2002-02-16 Depot medicinal products, carrier materials for depot medicinal products and processes for their production
PCT/EP2003/000725 WO2003068192A1 (en) 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Publications (1)

Publication Number Publication Date
IL162868A0 true IL162868A0 (en) 2005-11-20

Family

ID=27674694

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16286803A IL162868A0 (en) 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof
IL162868A IL162868A (en) 2002-02-16 2004-07-05 Depot medicament, carrier materials for depot medicaments and method for the production thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162868A IL162868A (en) 2002-02-16 2004-07-05 Depot medicament, carrier materials for depot medicaments and method for the production thereof

Country Status (17)

Country Link
EP (1) EP1474110B1 (en)
AT (1) ATE369123T1 (en)
AU (1) AU2003210181A1 (en)
BR (1) BR0307675A (en)
DE (2) DE10206517A1 (en)
DK (1) DK1474110T3 (en)
EA (1) EA006988B1 (en)
ES (1) ES2289304T3 (en)
HU (1) HUP0500119A3 (en)
IL (2) IL162868A0 (en)
MX (1) MXPA04006982A (en)
NO (1) NO20043860L (en)
NZ (1) NZ533103A (en)
PL (1) PL371785A1 (en)
PT (1) PT1474110E (en)
WO (1) WO2003068192A1 (en)
ZA (1) ZA200403979B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060682A1 (en) * 2006-12-19 2008-06-20 Sicit Chemitech S P A NEW BIODEGRADABLE POLYMER DERIVATIVES
DE102007011606A1 (en) 2007-03-02 2008-09-04 Carl Freudenberg Kg Fiber-tangled structure useful as cell settling material, wound covering, medical implant and carriers for pharmaceutical active substance and for producing depot medicament, comprises fibers made of partially interlaced gelatin material

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
DK0814778T3 (en) * 1995-03-10 2001-09-17 Roche Diagnostics Gmbh Polypeptide-containing pharmaceutical administration forms in the form of microparticles and their method of preparation
DE19813174A1 (en) * 1998-03-25 1999-05-27 Schering Ag Gas-filled microparticles, used for administering biologically active substances
CA2370357C (en) * 1999-04-16 2007-04-10 Wm. Marsh Rice University Poly(propylene fumarate) cross linked with poly(ethylene glycol)

Also Published As

Publication number Publication date
WO2003068192A1 (en) 2003-08-21
EP1474110B1 (en) 2007-08-08
BR0307675A (en) 2005-01-11
ZA200403979B (en) 2004-11-29
PT1474110E (en) 2007-10-01
EA200401012A1 (en) 2005-04-28
HUP0500119A3 (en) 2008-04-28
ES2289304T3 (en) 2008-02-01
EP1474110A1 (en) 2004-11-10
ATE369123T1 (en) 2007-08-15
IL162868A (en) 2008-03-20
MXPA04006982A (en) 2004-11-10
DE10206517A1 (en) 2003-09-04
EA006988B1 (en) 2006-06-30
NO20043860L (en) 2004-09-15
DE50307874D1 (en) 2007-09-20
NZ533103A (en) 2007-04-27
HUP0500119A2 (en) 2005-07-28
AU2003210181A1 (en) 2003-09-04
DK1474110T3 (en) 2007-12-10
PL371785A1 (en) 2005-06-27

Similar Documents

Publication Publication Date Title
DE60018600D1 (en) BIOACTIVE COMPOUND COMPOSITE FOR "TISSUE ENGINEERING"
AU2586201A (en) Recycling of articles comprising hydroxy-phenoxyether polymers
DE60018455D1 (en) DOUBLE FILMS VACUUM INJECTION METHOD FOR THE PRODUCTION OF A COMPOSITE MATERIAL AND COMPOSITE MATERIAL PRODUCED THEREWITH
MXPA04006545A (en) Novel pharmaceutical dosage forms and method for producing same.
DE602006014692D1 (en) FILM WITH CLEANER
CA2106451A1 (en) Isocyanate-Based Elastomer and Process for Production Thereof
DE69426196D1 (en) METHOD FOR PRODUCING A BIODEGRADABLE MATERIAL FOR THE DELAYED RELEASE OF A MEDICINAL PRODUCT, AND MATERIAL SO PRODUCED THEREOF
BRPI0505635A (en) polyurethane molded article and production method
WO2001028591A3 (en) Injection vehicle for polymer-based formulations
DE69602517D1 (en) BIODEGRADABLE AND COMPOSTABLE POLYMERS MADE FROM CONJUGATED SERVES LIKE ISOPRENE OR 2,3-DIMETHYL-1,3-BUTADIENE
MY143992A (en) Smoking articles and smokable filler material therefor
DE602005003343D1 (en) MEDICINAL PRODUCTS WITH HIDDEN TASTE IN BREAKING MULTIPARTICLES
MXPA03003473A (en) Methods of producing oxazolidinone compounds.
MXPA05012750A (en) Composition for forming an elastomeric article.
AU2002229539A1 (en) Novel polyesters, method for producing the same and depot medicaments produced from these polyesters
DE50206912D1 (en) METHOD FOR CONTINUOUS PRODUCTION AND COATING OF SBC-BASED SELF-CONTAINING MATERIALS WITH AT LEAST ONE PHARMACEUTICAL AGENT
EP1469886B8 (en) Lyophilized pharmaceutical composition of propofol
DE602005009734D1 (en) IAL AND THERMOPLASTIC OR ELASTOMER MATERIAL AND METHOD FOR PRODUCING THE ARTICLE
ATE441359T1 (en) STETHOSCOPE
IL162868A0 (en) Depot medicament, carrier materials for depot medicaments, and method for the production thereof
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
IL155446A0 (en) Polycarbonate composite material which can be thermoplastically shaped, methods for the production thereof, use of the same and a flame-proof polycarbonate moulded part
KR100639106B1 (en) Degradable resin composition and method for producing thereof
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
WO2005009711A3 (en) Implant with improved homogeneity for plastic surgery and method fo the production thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed